Full Access
Relationship of epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and vimentin expression and various prognostic factors in breast cancer patients
H. KOUTSELINI,
CH. MARKOPOULOS,
S. LAMBROPOULOU,
H. GOGAS, CH. KANDARAKI,
J. GOGAS,
Corresponding Author
H. KOUTSELINI
Department of Cytopathology, Evangelismos Hospital.
H. Koutselini MD, MIAC, Ass. Professor of Pathology, 10 Ravine Street, Athens 115 21, Greece.Search for more papers by this authorCH. MARKOPOULOS
2nd Prop. Department of Surgery, Medical School, University of Athens, Athens, Greece.
Search for more papers by this authorS. LAMBROPOULOU
Department of Cytopathology, Evangelismos Hospital.
Search for more papers by this authorCH. KANDARAKI
Department of Cytopathology, Evangelismos Hospital.
Search for more papers by this authorJ. GOGAS
2nd Prop. Department of Surgery, Medical School, University of Athens, Athens, Greece.
Search for more papers by this authorH. KOUTSELINI,
CH. MARKOPOULOS,
S. LAMBROPOULOU,
H. GOGAS, CH. KANDARAKI,
J. GOGAS,
Corresponding Author
H. KOUTSELINI
Department of Cytopathology, Evangelismos Hospital.
H. Koutselini MD, MIAC, Ass. Professor of Pathology, 10 Ravine Street, Athens 115 21, Greece.Search for more papers by this authorCH. MARKOPOULOS
2nd Prop. Department of Surgery, Medical School, University of Athens, Athens, Greece.
Search for more papers by this authorS. LAMBROPOULOU
Department of Cytopathology, Evangelismos Hospital.
Search for more papers by this authorCH. KANDARAKI
Department of Cytopathology, Evangelismos Hospital.
Search for more papers by this authorJ. GOGAS
2nd Prop. Department of Surgery, Medical School, University of Athens, Athens, Greece.
Search for more papers by this author
References
- 1 Raymond WA, Leong AS-Y. Vimentin—a new prognostic parameter in breast carcinoma. J Pathol 1989; 158: 107–14.
- 2 Hall PA, Levison DA. Review: assessment of cell proliferation in histological material. J Clin Pathol 1990; 43: 531–49.
- 3 Lippman ME, Dickson RB, Kasid A et al. Autocrine and paracrine growth regulation of human breast cancer. J Steroid Biochem 1986; 24: 147–54.
- 4 Solomon DS, Zwiebel JA, Bano M et al. Presence of transforming growth factors in human breast cancer cells. Cancer Res 1984; 44: 4069–77.
- 5 Stoscheck CM, King IE. Role of epidermal growth factor in carcinogenesis. Cancer Res 1986; 46: 1030–7.
- 6 Heidin CH, Westermark B. Growth factors. Mechanisms of action and relation to oncogenes. Cell 1984; 37: 9–15.
- 7 Carpenter G, Zendecut JF. Epidermal growth factor, its receptor and related proteins. Exp Cell Res 1986; 164: 1–10.
- 8 Real FX, Retting WJ, Chesa PG, Melamed MR, Old LJ, Mendelsohn J. Expression of epidermal growth factor receptor in human culture cells and stage of differentiation. Cancer Res 1986; 46: 4726–31.
- 9
Hwang DL,
Tay YC,
Lin SS,
Lev-Ran A.
Expression of epidermal growth factor receptors in human lung tumors.
Cancer
1986; 58: 2260–3.
10.1002/1097-0142(19861115)58:10<2260::AID-CNCR2820581017>3.0.CO;2-U CAS PubMed Web of Science® Google Scholar
- 10
Costrini NV,
Beck R.
Epidermal growth factor: urogastrone receptors in normal human liver and primary hepatoma.
Cancer
1983; 51: 2191–6.
10.1002/1097-0142(19830615)51:12<2191::AID-CNCR2820511207>3.0.CO;2-Q CAS PubMed Web of Science® Google Scholar
- 11 Liberman TA, Razon N, Bartal AD, Yarden Y, Schlesinger J, Soreg H. Expression of epidermal growth factor receptors in human brain tumors. Cancer Res 1984; 44: 753–60.
- 12 Prelich G, Tan CK, Kostura M et al. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 1987; 326: 517–20.
- 13 Hall PA, Levison DA, Woods AL et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990; 162: 285–94.
- 14 Battersby S, Anderson TJ. Correlation of proliferative activity in breast tissue using PCNA/cyclin. Hum Pathol 1990; 21: 781.
- 15 Woods AL, Hanby AM, Hall PA, Wasseem N, Lane DP, Levison D. The prognostic value of PCNA (proliferating cell nuclear antigen) immunostaining in gastro-intestinal lymphomas. J Pathol 1990; 161: 342.
- 16 Domagala W, Wozniack L, Lasota J, Weber K, Osborn M. Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas. Am J Pathol 1990; 137: 1059–64.
- 17 Domagala W, Lacosta J, Bartkowiak J, Weber K, Osborn M. Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high K1-67 growth fraction. Am J Pathol 1990; 136: 219–27.
- 18 Leader M, Collins M, Pattel J, Henry K. Vimentin: an evaluation of its role as a tumour marker. Histopathology 1987; 11: 63–72.
- 19 Gould VE. Histogenesis and differentiation: a reevaluation of these concepts as criteria for the classification of tumours. Hum Pathol 1986; 17: 212–4.
- 20 Sorft RW, Tortoni H. Histological Typing of Breast Tumors. International Histological Classification of Tumors (IHCT) 2. Geneva : World Health Organization, 1968.
- 21 Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957; 11: 359–77.
- 22 Fisher ER. Prognostic and therapeutic significance of pathological features of breast cancer. Natl Cancer Inst, Monogr 1986; 1: 29–34.
- 23
Butler JA,
Bretsky S,
Menendez-Botel C,
Kinne DW.
Estrogen receptor protein of breast cancer as a predictor of recurrence.
Cancer
1985; 55: 1178–81.
10.1002/1097-0142(19850315)55:6<1178::AID-CNCR2820550606>3.0.CO;2-U CAS PubMed Web of Science® Google Scholar
- 24 Leong AS-Y, Raymond WA. Update: prognostic parameters in breast cancer. Pathology 1989; 21: 169–75.
- 25 Sainsbury JRC, Malcolm AJ, Appleton DR et al. Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 1985; 38: 1225–8.
- 26 Sainsbury JRC, Farndon JR, Needham GK et al. Epidermal growth factor receptor status as predictor of early recurrence and death from breast cancer. Lancet 1987; 1: 1398–402.
- 27 Woods AL, Hall PA, Shepherd NA, Hanby AM, Waseem NH, Lane DP, Levison DA. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2+ M phase fraction (flow cytometric analysis) and prognosis. Histopathology 1991; 19: 21–27.
- 28 Jain S, Filipe MI, Hall PA, Waseem N, Lane DP, Levison DA. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol 1991; 44: 655–9.
- 29 Tubiana M, Courdi A. Cell proliferation kinetics in human solid tumours: relation to probability of metastatic dissemination and long term survival. Radiother Oncol 1989; 15: 1–18.
- 30 Skoog L, Macias A, Azavedo E, Lombardero J, Klitenberg C. Receptors for EGF and oestradiol and thymidine kinase activity in different histological subgroups of human mammary carcinomas. Br J Cancer 1986; 54: 271–6.
- 31 Walker RA, Campleton RS. DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors. J Pathol 1986; 150: 37–42.
- 32 Jakesz R, Smith CA, Aitken S et al. Influence of cell proliferation and cell cycle phase on expression of estrogen receptor on MCF-7 breast cancer cells. Cancer Res 1984; 44: 619.
Citing Literature
